SCHEMBL5663030

SCHEMBL5663030

CCC(Oc1ccc(OC(C)(C)C(=O)OC(=O)[C@@H](N)CCCNC(=N)N)cc1)n1ccc2cc(OS(C)(=O)=O)ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5660227 0.84 MCL1 (0.38) —
SCHEMBL5661026 0.84 MTNR1A (0.35) —
SCHEMBL5660659 0.83 PPARA (0.33) —
SCHEMBL5664183 0.81 PPARA (0.42) —
SCHEMBL5661036 0.80 PPARA (0.35) —
SCHEMBL5660965 0.80 PPARA (0.32) —
SCHEMBL5660731 0.80 PPARA (0.33) —
SCHEMBL5662393 0.79 CA12 (0.36) —
SCHEMBL5663040 0.78 PPARA (0.37) —
SCHEMBL5658608 0.77 PPARA (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093476-A1 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2007-04-26 — — US disclosed
Send feedback